Vaccine—screening method

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9833506
SERIAL NO

14366602

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention provides screening methods which may be regarded as in vitro or ex vivo methods of interrogating the immune system to understand what viral antigens are “seen” and responded to by T cells of the immune systems during viral infection. The screening methods further link in vitro or ex vivo responses to progression of infection in subjects.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
POOLBEG PHARMA (UK) LIMITED40 BANK STREET FLOOR 24 LONDON E14 5NR

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Lambkin-Williams, Robert Brighton, GB 4 46
Oxford, John S London, GB 3 19
Wilkinson, Thomas Hampshire, GB 12 31

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Jun 5, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jun 5, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00